Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study

por Broët, P, Spyratos, F, Romain, S, Quillien, V, Daver, A, Ricolleau, G, Rallet, A, Toulas, C, Asselain, B
Publicado 1999

Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers.

por Pichon, M. F., Broet, P., Magdelenat, H., Delarue, J. C., Spyratos, F., Basuyau, J. P., Saez, S., Rallet, A., Courriere, P., Millon, R., Asselain, B.
Publicado 1996

Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GIN...

por Elie, C, Geay, J F, Morcos, M, Le Tourneau, A, Girre, V, Broët, P, Marmey, B, Chauvenet, L, Audouin, J, Pujade-Lauraine, E, Camilleri-Broët, S
Publicado 2004

10(th) European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals

por Tourdot, S., Abdolzade-Bavil, A., Bessa, J., Broët, P., Fogdell-Hahn, A., Giorgi, M., Jawa, V., Kuranda, K., Legrand, N., Pattijn, S., Pedras-Vasconcelos, J. A., Rudy, A., Salmikangas, P., Scott, D. W., Snoeck, V., Smith, N., Spindeldreher, S., Kramer, D.
Publicado 2020

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative...

por Rup, B, Pallardy, M, Sikkema, D, Albert, T, Allez, M, Broet, P, Carini, C, Creeke, P, Davidson, J, De Vries, N, Finco, D, Fogdell-Hahn, A, Havrdova, E, Hincelin-Mery, A, C Holland, M, H Jensen, P E, Jury, E C, Kirby, H, Kramer, D, Lacroix-Desmazes, S, Legrand, J, Maggi, E, Maillère, B, Mariette, X, Mauri, C, Mikol, V, Mulleman, D, Oldenburg, J, Paintaud, G, R Pedersen, C, Ruperto, N, Seitz, R, Spindeldreher, S, Deisenhammer, F
Publicado 2015